Search results will open in a new window on

Exchange Bulletin

CanniMed Therapeutics Inc. (CMED) To Trade On Toronto Stock Exchange

December 23, 2016
Issuer: CanniMed Therapeutics Inc. (the "Company")
Security: Common shares (the "Shares")
Symbol(s): CMED
Issue price per security: $12.00
Number of securities issued and outstanding: 19,843,505
Number of securities reserved for issuance: 7,454,903
Listing category: Industrial, Non Exempt
CUSIP: 13767U 10 9
Trading currency: CDN$
Transaction: Initial public offering (the "Offering").
Listing date: December 28, 2016 (as at 5:01 pm) in anticipation of closing of the Offering.
Anticipated closing date: December 29, 2016 (prior to the opening)
Posted for trading date: December 29, 2016 (at the opening) subject to confirmation of closing of the Offering.
Other market(s): None
Temporary market maker: AltaCorp Capital Inc.
Security ownership registration: Non-certificated inventory
Investor relations: Dara Willis
Incorporation: Canada Business Corporations Act
Fiscal year end: October 31
Nature of business: The Company is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian medical cannabis industry, with 15 years' of pharmaceutical cannabis cultivation experience, a state-of-the-art, GMP-compliant plant production process, including 281 points of quality control, and world class research and development platforms with a wide range of pharmaceutical-grade cannabis products.
Transfer agent and registrar: Computershare Investor Services Inc. at its principal office in Toronto.
Dividends: The Company has not paid dividends to its shareholders to date and does not anticipate paying cash dividends on the Shares in the foreseeable future. The Company's current policy is to retain cash flows to finance the development and enhancement of its products and to otherwise reinvest in the Company's business.
Sponsorship: Waived
Disclosure document: Prospectus dated December 21, 2016 which is available at
Initial public offering: 5,000,000 Shares are being offered to the public from treasury at a price of $12.00 per Share (the "Offering Price"). In addition, the underwriters have been granted an over-allotment option to purchase up to an additional 750,000 Shares from treasury at the Offering Price.
TSX contact: Julie K. Shin,
Director, Listed Issuer Services,
Toronto Stock Exchange.